Skip to main content
GAM Holding AG logo

GAM Holding AG — Investor Relations & Filings

Ticker · GAM ISIN · CH0102659627 LEI · 549300GGVID7ZGDMX291 SW Financial and insurance activities
Open in API
Filings indexed 55 across all filing types
Latest filing 2023-04-25 Regulatory Filings
Country CH Switzerland
Listing SW GAM

About GAM Holding AG

https://www.gam.com/

GAM Holding AG is an independent, pure-play global asset management group. The firm provides active investment management services to a wide range of clients, including institutions, financial intermediaries, and private investors. It offers distinctive investment strategies across multiple asset classes, with specialized capabilities in areas such as emerging market debt, multi-asset solutions, and sustainable investing. The company's core mission is to protect and enhance its clients' financial future through responsible and diligent investment approaches.

Recent filings

Filing Released Lang Actions
Form 8.3 - Medica Group PLC
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and concerns 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This form relates to insider dealing disclosures during a takeover situation. While it contains specific transaction details, the primary function is a regulatory disclosure related to ownership changes during a corporate action (takeover bid for Medica Group PLC). This type of specific regulatory filing, which is not a standard periodic report (10-K, IR) or a general announcement (RNS), fits best under the category for specific regulatory disclosures or, given the context of insider dealing/ownership changes, it is a highly specific regulatory filing. Since there is no specific code for 'Takeover Code Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, the most appropriate general category for mandatory, non-standard regulatory disclosures is 'RNS' (Regulatory Filings), as it is a specific regulatory filing type that doesn't match the other defined categories like DIRS (Director's Dealing, which is usually Form 3/4/5 related) or MRQ (Major Shareholding Notification, which is usually for crossing 3% or 5% thresholds outside of a takeover context). Given the structure and source (RNS Number), it is a regulatory announcement.
2023-04-25 English
Form 8.3 - Devro Plc
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code'. This form is a mandatory disclosure related to insider or significant shareholder dealings during a takeover or merger situation. While it involves director/insider activity (similar to DIRS), the specific context of a Takeover Code disclosure (Form 8.3) is a specialized regulatory filing related to M&A activity or significant ownership changes during such events. Since there is no specific code for 'Takeover Disclosure Form 8.3', we must choose the closest fit. It is a regulatory filing (RNS), but more specifically, it relates to ownership changes during a potential takeover (TAR). However, Form 8.3 is fundamentally a disclosure of interests/dealings, which often falls under general regulatory announcements or insider dealing reports. Given the structure and the explicit mention of RNS and the London Stock Exchange distribution service, it is a regulatory filing. Since it details dealings and positions related to an offeror/offeree (Devro plc), it is highly specific. The closest general category for mandatory regulatory disclosures not covered by specific financial reports (10-K, ER, IR) is RNS. If we consider the content (dealing disclosure), DIRS is relevant, but DIRS is usually for routine director transactions, whereas this is tied to a specific 'Offer' under the Takeover Code. Given the context of mandatory disclosure via RNS, 'RNS' (Regulatory Filings) is the most appropriate general classification for this type of official, non-financial report filing.
2022-12-07 English
Form 8.3 - Devro plc / Saria Nederland B.V.
Regulatory Filings Classification · 98% confidence The document is explicitly titled 'FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' and references 'Rule 8.3 of the Takeover Code'. This form relates to disclosures required during a takeover situation concerning dealings by parties involved. While it contains specific transaction details, its primary function is a regulatory disclosure related to a takeover bid (mentioning 'offeror/offeree' and 'Devro plc'). This type of specific regulatory filing, which details insider/major shareholder activity during a takeover context, is best classified under the general 'Regulatory Filings' category (RNS) as there is no specific code for 'Takeover Disclosure Form 8.3'. It is not a Director's Dealing (DIRS) as it pertains to a corporate entity (GAM Holding AG) in the context of an offer, nor is it a general M&A Activity announcement (TAR), but rather a specific disclosure form related to the ongoing process.
2022-12-06 English
Form 8.3 - Devro PLC
Regulatory Filings Classification · 98% confidence The document explicitly states it is a 'FORM 8.3' concerning 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE' under 'Rule 8.3 of the Takeover Code'. This type of disclosure relates to insider dealings or significant ownership changes during a takeover scenario. While it involves dealing disclosure, the specific context of Rule 8.3 (Takeover Code) and the nature of the disclosure (position/dealing disclosure related to an offer) strongly aligns with insider transaction reporting, which is often captured under Director's Dealing (DIRS) or, more broadly, as a specific regulatory filing. However, looking at the provided definitions, 'Director's Dealing (DIRS)' covers personal share transactions by directors/executives. This document is a disclosure by GAM Holding AG regarding its position in Devro plc during an offer period, which is a specific type of insider/significant shareholder disclosure related to market activity, not necessarily a director's personal trade, but certainly a regulatory filing concerning ownership/dealing. Since there is no specific code for 'Takeover Code Disclosure Form 8.3', and it details dealings/positions, it is best classified as a specific regulatory filing that doesn't fit the other categories. The presence of 'RNS Number' and the closing statement referencing 'RNS, the news service of the London Stock Exchange' suggests it is a general regulatory announcement. Given the highly specific nature of the content (Form 8.3), it is a regulatory filing. If 'DIRS' is interpreted narrowly as only director personal trades, then 'RNS' (General regulatory announcements/fallback) is the most appropriate general category for a mandatory filing like this that isn't a core financial report (10-K, IR, ER). However, since it is a disclosure of interests/dealings, it is closely related to DIRS. Given the options, and the fact that it is a mandatory disclosure under a specific regulatory framework (Takeover Code), it fits best under the general 'Regulatory Filings' (RNS) as it is not a standard DIRS filing (which usually refers to insider trading reports like Form 4 or DTR3/DTR2 filings in the UK context, rather than takeover-related position disclosures). I will classify it as RNS as the most appropriate fallback for a specific, non-standard regulatory disclosure.
2022-12-02 English
Form 8.3 - Devro Plc
Regulatory Filings Classification · 95% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code (the "Code")'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider/significant shareholder activity during a takeover scenario. While it contains elements of director/insider dealing (DIRS), the specific context of the Takeover Code (Rule 8.3) and the nature of the disclosure (position disclosure related to an offer for Devro plc) makes it a specialized regulatory filing concerning market activity during a potential M&A event. Since there is no specific code for 'Takeover Disclosure Form 8.3', and it is a mandatory regulatory filing disseminated via RNS, it falls best under the general 'Regulatory Filings' (RNS) category, as it is not a standard DIRS report (which usually relates to Form 3, 4, or 5 equivalents in the US context, or general director dealings outside of a formal takeover code context). Given the explicit reference to RNS at the end ('This information is provided by RNS...'), RNS is the most appropriate general regulatory classification.
2022-12-01 English
Form 8.3 - Devro PLC
Major Shareholding Notification Classification · 96% confidence The document is explicitly titled 'FORM 8.3' and references 'Rule 8.3 of the Takeover Code'. This form is a 'PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE'. This type of disclosure relates to insider/significant shareholder dealings during a takeover scenario. While it involves dealings, the specific regulatory form (Form 8.3) is a specialized disclosure related to takeover activity, which is not explicitly covered by 'DIRS' (Director's Dealing) which usually refers to standard insider transaction reports (like Form 4 or DTR3). Since it is a specific regulatory filing related to a takeover, and the document structure is a standardized regulatory form, it fits best under the general 'Regulatory Filings' (RNS) category as a specific, non-standard report, or potentially 'TAR' (M&A Activity) due to the Takeover Code reference. However, 'RNS' is the most appropriate general category for standardized regulatory disclosures that don't fit the other specific categories like 10-K, ER, or DIV. Given the context of the Takeover Code and dealing disclosures, 'RNS' serves as the best fit for this specific regulatory form submission.
2022-11-30 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.